000 | 01544 a2200397 4500 | ||
---|---|---|---|
005 | 20250518015832.0 | ||
264 | 0 | _c20200218 | |
008 | 202002s 0 0 eng d | ||
022 | _a1365-2249 | ||
024 | 7 |
_a10.1111/cei.13260 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRodrÃguez-Perea, A L | |
245 | 0 | 0 |
_aHigh concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells. _h[electronic resource] |
260 |
_bClinical and experimental immunology _c05 2019 |
||
300 |
_a237-248 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
650 | 0 | 4 |
_aAtorvastatin _xpharmacology |
650 | 0 | 4 |
_aCTLA-4 Antigen _xmetabolism |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCytokines _xmetabolism |
650 | 0 | 4 |
_aFlow Cytometry _xmethods |
650 | 0 | 4 |
_aForkhead Transcription Factors _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-2 _xmetabolism |
650 | 0 | 4 |
_aLeukocyte Common Antigens _xmetabolism |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _xdrug effects |
650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xmetabolism |
650 | 0 | 4 |
_aReceptors, CCR7 _xmetabolism |
650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _xdrug effects |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
700 | 1 | _aRojas, M | |
700 | 1 | _aVelilla-Hernández, P A | |
773 | 0 |
_tClinical and experimental immunology _gvol. 196 _gno. 2 _gp. 237-248 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/cei.13260 _zAvailable from publisher's website |
999 |
_c29249379 _d29249379 |